TEVA: Volume dana dhuwit perusahaan Teva Pharmaceutical Industries

Teva Pharmaceutical Industries maintains its leadership in the generics sector, leveraging mass production. The company's cash position confirms this status, with the current amount standing at 4.08. However, massive debts and litigation are weighing on profits. To stabilize, the holding is introducing conservative biosimilars, gradually updating its drug portfolio to enhance business resilience.
Rincian metrik keuangan lan pasar tevapharm.com (TEVA)

This metric aggregates current account balances and cash equivalents, reflecting the company's immediate liquidity. It allows for an assessment of the business's ability to cover short-term liabilities without resorting to external financing. For Teva Pharmaceutical Industries (TEVA), such reserves are critical for maintaining large-scale API production and managing global generics logistics. Analyzing the cash asset volume helps determine the balance between financial stability and capital efficiency.